 | Opioid Use Disorder Market to Soar at 10.8% CAGR and Hit USD 4.50 Billion by 2026; Increasing Research in Opioids by Pharmaceuticals to Aid Market Expansion: Fortune Business Insights™
benzinga.com - November 23 at 7:21 AM |
 | UK EXECUTIVE CHANGE SUMMARY: New CFOs For Indivior And Costain
lse.co.uk - November 20 at 1:03 PM |
 | Drugmaker Indivior appoints Preblick as permanent finance chief
reuters.com - November 20 at 1:03 PM |
 | Indivior PLC (OTCMKTS:INVVY) Short Interest Update
americanbankingnews.com - November 19 at 9:34 PM |
| Indivior Promotes Former Shire CFO Graham Hetherington To Chair
lse.co.uk - November 19 at 8:15 AM |
| Indivior PLC to Post FY2020 Earnings of $0.25 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:INVVY)
americanbankingnews.com - November 18 at 6:17 AM |
| Indivior PLC (OTCMKTS:INVVY) Forecasted to Earn FY2023 Earnings of $0.90 Per Share
americanbankingnews.com - November 17 at 6:49 AM |
| Indivior Happy To Put Suboxone Matter Behind It As Court Approves Deal
lse.co.uk - November 13 at 9:22 AM |
 | Indivior hit with $600 million in civil and criminal penalties over marketing of opioid addiction treatment
msn.com - November 12 at 6:22 PM |
 | Indivior PLC Beat Revenue Forecasts By 11%: Here's What Analysts Are Forecasting Next
finance.yahoo.com - November 1 at 7:41 AM |
|
| Indivior PLC (OTCMKTS:INVVY) Short Interest Down 26.3% in October
americanbankingnews.com - October 31 at 7:20 PM |
 | Indivior PLC 2020 Q3 - Results - Earnings Call Presentation
seekingalpha.com - October 31 at 2:37 PM |
| Indivior Reinstates Annual Guidance; Quarterly Profit Falls 79%
lse.co.uk - October 29 at 12:01 PM |
| CORRECTED-Indivior quarterly profit slumps, sets full-year revenue target
reuters.com - October 29 at 12:01 PM |
| Indivior Says Former CEO Thaxter's US Sentencing Not Related
lse.co.uk - October 23 at 8:15 AM |
 | Indivior Calls for Widespread Commitment to Tackling Stigma in Patients with Opioid Use Disorder
prnewswire.com - September 30 at 8:41 AM |
| Indivior to restructure, axe jobs as it looks to cut costs
seekingalpha.com - September 24 at 12:47 PM |
| Indivior Reorganises Amid Challenges; Still In Line With Expectations
lse.co.uk - September 24 at 7:47 AM |
| Indivior Takes Strategic Alignment Actions
finance.yahoo.com - September 24 at 7:47 AM |
| Indivior PLC 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 30 at 3:09 PM |
| Indivior second-quarter profit falls 73% as coronavirus curbs dent demand
finance.yahoo.com - July 30 at 10:09 AM |
| Indivior can't reverse Suboxone antitrust class certification
www.reuters.com - July 29 at 8:01 AM |
| Indivior to pay $600 million to settle U.S. opioid treatment marketing claims
finance.yahoo.com - July 25 at 6:00 AM |
 | Indivior to pay $600-million to settle U.S. opioid treatment marketing claims
www.theglobeandmail.com - July 24 at 5:54 PM |
| Indivior Finance S.ar.l. -- Moody's affirms Indivior's B3 CFR; outlook revised to stable
finance.yahoo.com - July 24 at 5:54 PM |
| UPDATE 1-Indivior to resolve U.S. opioid treatment marketing claims for $600 million
www.reuters.com - July 24 at 12:54 PM |
| Indivior to pay $600 million to resolve U.S. opioid treatment marketing claims
www.reuters.com - July 24 at 12:54 PM |
| Indivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® Film
finance.yahoo.com - July 24 at 12:54 PM |
| Ex-CEO of opioid treatment maker Indivior pleads guilty in U.S.
www.reuters.com - July 2 at 8:53 AM |
| Indivior Notes Former CEO's US DoJ Plea In "Personal Capacity"
www.lse.co.uk - July 1 at 8:06 AM |
|
| Ex-CEO of opioid treatment maker Indivior pleads guilty in U.S
www.reuters.com - June 30 at 7:29 PM |
| US Government Agreement With Former CEO
finance.yahoo.com - June 30 at 7:29 PM |
| Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs
www.lse.co.uk - June 29 at 8:20 AM |
| Indivior's Sublocade shows sustained benefit in long-term observational study
seekingalpha.com - June 24 at 12:32 PM |
| New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting
finance.yahoo.com - June 24 at 12:32 PM |
| Indivior Chair Howard Pien Takes Medical Leave Of Absence
www.lse.co.uk - June 15 at 10:02 AM |
| North America Synthetic Opioids Market to reach US$ 97.6 Billion by end of 2027 – Coherent Market Insights
www.benzinga.com - May 28 at 10:20 PM |
 | LOST MONEY IN INDIVIOR (INVVY) PLC? Class Action Lawsuit Filed to Recover Indivior Investors’ Losses, Gibbs Law Group
www.bloomberg.com - May 25 at 11:14 PM |
| Indivior PLC (INVVY) CEO Shaun Thaxter on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 1:23 AM |
 | Indivior PLC (INDV.L)
uk.finance.yahoo.com - May 14 at 6:11 PM |
 | Indivior PLC ADR
www.barrons.com - May 14 at 6:11 PM |
| Indivior Q1 2020 Results Now Available; Conference Call With Leadership Today
finance.yahoo.com - May 14 at 8:10 AM |
| Indivior profit slumps on legal costs, higher litigation provisions
finance.yahoo.com - May 14 at 8:10 AM |
| Reckitt Benckiser Treasury Services Plc -- Moody's assigns A3 ratings to Reckitt Benckiser's new unsecured notes; outlook negative
finance.yahoo.com - May 11 at 3:54 PM |
| BRIEF-Indivior Gets Nod For Subutex For Substitution Treatment Of Opioid Dependence In Sweden
www.reuters.com - May 6 at 12:28 PM |
| Indivior withdraws 2020 forecast on coronavirus-led uncertainty
finance.yahoo.com - April 8 at 7:07 AM |
 | Oral Thin Film Drug Market Global Insights and Top Pharma Companies 2020
www.marketwatch.com - February 14 at 7:31 AM |
| Indivior PLC 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 13 at 2:47 PM |
| SHAREHOLDER ALERT - Indivior PLC (INVVY) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline:
www.bloomberg.com - February 11 at 10:08 PM |
| Are Insiders Buying Indivior PLC (LON:INDV) Stock?
finance.yahoo.com - February 11 at 7:06 AM |
